Authors:
Aviezer, D
Seddon, AP
Wildey, MJ
Bohlen, P
Yayon, A
Citation: D. Aviezer et al., Development of a high throughput screening assay for inhibitors of fibroblast growth factor-receptor-heparin interactions, J BIOMOL SC, 6(3), 2001, pp. 171-177
Citation: Z. Landau et al., Heparin-like inhibitory activity to fibroblast growth factor-2 in wound fluids of patients with chronic skin ulcers and its modulation during wound healing, WOUND R REG, 9(4), 2001, pp. 323-328
Citation: D. Robinson et al., Characteristics of cartilage biopsies used for antologous chondrocytes transplantation, CELL TRANSP, 10(2), 2001, pp. 203-208
Authors:
Robinson, D
Ash, H
Aviezer, D
Agar, G
Halperin, N
Nevo, Z
Citation: D. Robinson et al., Autologous chondrocyte transplantation for reconstruction of isolated joint defects: the Assaf Harofeh experience, ISR MED ASS, 2(4), 2000, pp. 290-295
Authors:
Safran, M
Eisenstein, M
Aviezer, D
Yayon, A
Citation: M. Safran et al., Oligomerization reduces heparin affinity but enhances receptor binding of fibroblast growth factor 2, BIOCHEM J, 345, 2000, pp. 107-113
Authors:
Aviezer, D
Cotton, S
David, M
Segev, A
Khaselev, N
Galili, N
Gross, Z
Yayon, A
Citation: D. Aviezer et al., Porphyrin analogues as novel antagonists of fibroblast growth factor and vascular endothelial growth factor receptor binding that inhibit endothelialcell proliferation, tumor progression, and metastasis, CANCER RES, 60(11), 2000, pp. 2973-2980
Citation: D. Aviezer et al., Heparin differentially regulates the interaction of fibroblast growth factor-4 with FGF receptors 1 and 2, BIOC BIOP R, 263(3), 1999, pp. 621-626